Latest Breaking News On - Fellowship fund in psychedelic neuroscience at massachusetts - Page 1 : vimarsana.com

- Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in cognitive

New yorkUnited statesSan diegoCity ofUnited kingdomCamilla dormerSrinivas raoOtsuka pharmaceuticalsFellowship fund in psychedelic neuroscience at massachusettsRecognify life sciencesHospital centerRevixia life sciencesExchange commissionMultidisciplinary association for psychedelics studiesViridia life sciencesLife sciences